2D graphene oxide-L-arginine-soybean lecithin nanogenerator for synergistic photothermal and NO gas therapy
2D graphene oxide-L-arginine-soybean lecithin nanogenerator for synergistic photothermal and NO gas therapy
复制标题
二维氧化石墨烯-L-精氨酸-大豆卵磷脂纳米发电机用于协同光热和一氧化氮气体治疗
DOI:
10.1016/j.cclet.2022.05.091
复制
发表时间:
2022-06
期刊:
影响因子:
--
通讯作者:
Jinxiao Mi
中科院分区:
文献类型:
--
作者:
Haina Tian;Jinyan Lin;Fukai Zhu;Jiaqi Li;Suhua Jiang;Liya Xie;Yang Li;Peiyuan Wang;Zhenqing Hou;Jinxiao Mi
Nitric oxide (NO) gas therapy has been regarded as a promising strategy for cancer treatment. However, its therapeutic efficiency is still unsatisfying due to the limitations of monotherapy. Previous preclinical and clinical studies have shown that combination therapy could significantly enhance therapeutic efficiency. Herein, a graphene oxide (GO)-L-arginine (L-Arg, a natural NO donor) hybrid nanogenerator is developed followed by surface functionalization of soybean lecithin (SL) for synergistic enhancement of cancer treatment through photothermal and gas therapy. The resultant GO-Arg-SL nanogenerator not only exhibited good biocompatibility and excellent endocytosis ability, but also exhibited excellent photothermal conversion capability and high sensitivity to release NO within tumor microenvironment via inducible NO synthase (iNOS) catalyzation. Moreover, the produced hyperthermia and intracellular NO could synergistically kill cancer cells both in vitro and in vivo . More importantly, this nanogenerator can efficiently eliminate tumor while inhibiting the tumor recurrence because of the immunogenic cell death (ICD) elicited by NIR laser-triggered hyperthermia and the immune response activation by massive NO generation. We envision that the GO-Arg-SL nanogenerator could provide a potential strategy for synergistic photothermal and gas therapy. Herein, a graphene oxide-L-arginine-soybean lecithin nanogenerator was designed for antitumor's synergistic photothermal and NO gas therapy. The nanogenerator can remarkably eliminate tumors, meanwhile efficiently cut down on the tumor recurrence rate attributed to immune activated by the synergistic therapy.
登录
查看更多内容
影响因子:
14
作者:
Lu, Qianglan;Lu, Tong;Li, Nan
通讯作者:
Li, Nan
影响因子:
15.1
作者:
Tiemuer, Aliya;Yu, Hui;Liu, Yi
通讯作者:
Liu, Yi
影响因子:
17.1
作者:
Zhou, Hui-fang;Yan, Huimin;Hu, Ying;Springer, Luke E.;Yang, Xiaoxia;Wickline, Samuel A.;Pan, Dipanjan;Lanza, Gregory M.;Pham, Christine T. N.
通讯作者:
Pham, Christine T. N.
影响因子:
12.4
作者:
Wang Z;Feng C;Zhao H;Ren X;Peng S;Zuo Z
通讯作者:
Zuo Z
影响因子:
7.3
作者:
Maciag AE;Holland RJ;Kim Y;Kumari V;Luthers CE;Sehareen WS;Biswas D;Morris NL;Ji X;Anderson LM;Saavedra JE;Keefer LK
通讯作者:
Keefer LK